|
Safety and efficacy of transcatheter left atrial
appendage closure using the Watchman device
in Egyptian patients with nonvalvular atrial
fibrillation
|
|
Bioresorbable Vascular Scaffold (ABSORB BVS); first report in Egyptian patients with 6 month angiographic/IVUS follow up
|
|
Percutaneous mitral repair with MitraClip system; safety and efficacy; initial Egyptian experience
|
|
Catheter-based radiofrequency renal sympathetic denervation for resistant hypertension; initial Egyptian experience
|
|
Acute effect of sildenafil on myocardial ischemic territories in patients with stable coronary artery disease
|
|
Short term follow-up of culprit only revascularization versus total revascularization in primary percutaneous coronary intervention in patients with multivessel disease
|
|
Bolus - only versus bolus followed by infusion of glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention
|
|
Evaluation of the effect of elective percutaneous coronary
intervention as a treatment method for right ventricular
function
|
|
Treatment of bifurcation lesions with a novel dedicated drug-eluting self expanding stent (AXXESS): single center first experience
|
|
|
Clinical outcomes of patients with long lesions treated with everolimus-eluting bioresorbable vascular scaffolds: a subgroup analysis from a single-centre all-comers absorb registry
|
|
|
Long term outcomes of patients with spontaneous coronary artery dissection
|
|
|
Six months outcome of rescue percutaneous coronary intervention compared to conservative treatment in patients with ST-segment elevation myocardial infarction with failed fibrinolytic therapy
|